These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 93697)

  • 41. The characterization of mycobacterial strains by the composition of their lipide extracts.
    SMITH DW; RANDALL HM; GASTAMBIDE-ODIER MM; KOEVOET AL
    Ann N Y Acad Sci; 1957 Sep; 69(1):145-57. PubMed ID: 13478997
    [No Abstract]   [Full Text] [Related]  

  • 42. The electrophoretic pattern of prostatic lipid secretion in normal and pathological conditions.
    NYLANDER G
    Scand J Clin Lab Invest; 1955; 7(3):250-3. PubMed ID: 13298602
    [No Abstract]   [Full Text] [Related]  

  • 43. Electrophoretic, nitrogen, lipide and enzyme studies of the plasma and plasma fractions in cancer.
    DILLARD GH; PEARSALL HR; CHANUTIN A
    Cancer Res; 1949 Nov; 9(11):661-4. PubMed ID: 15392830
    [No Abstract]   [Full Text] [Related]  

  • 44. Preparation of lipide extracts from brain tissue.
    FOLCH J; ASCOLI I; LEES M; MEATH JA; LeBARON N
    J Biol Chem; 1951 Aug; 191(2):833-41. PubMed ID: 14861228
    [No Abstract]   [Full Text] [Related]  

  • 45. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of the prostatic puncture biopsy in the diagnosis of prostatic cancer. Apropos of 271 cases].
    Perrin P; Mouriquand P; Delorme E; Grisard M; Dutrieux-Berger N; Dassonville F
    J Urol (Paris); 1986; 92(9):601-4. PubMed ID: 2434575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer].
    Pflüger H; Kirchheimer J; Ritschl P; Köller A; Hienert G; Binder BR
    Wien Klin Wochenschr; 1984 Sep; 96(17):658-61. PubMed ID: 6083673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnosis value of lipid content in prostatic cancer].
    Krajczár G; Szokol M
    Morphol Igazsagugyi Orv Sz; 1979 Oct; 19(4):282-6. PubMed ID: 93697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Allergic vasculitis in benign prostatic hyperplasia combined with a latent prostatic carcinoma].
    Shmurun RI
    Urol Nefrol (Mosk); 1997; (5):46-9. PubMed ID: 9412017
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.